Share this article
Share this article
USD 2.22 billion by 2028. according to a new study conducted by
Polaris Market Research. the market is anticipated to register a
CAGR of 9.1% from
2021 – 2028. Increasing incidences of accidents leading to organ damage coupled with a growing geriatric population resulting in a rise in count people with non-functioning of organs drive demand for scaffold technology solutions. The rising demand for body reconstruction procedures and the increasing rate of organ transplantations conducted globally further drives the market growth. Furthermore, increasing R&D activities related to developing matrix-based 3D substrates that allow interactivity among implants and host microenvironment to ensure optimal functioning of the implanted cells is anticipated to fuel the market in terms of revenue growth over the forecast period.
kits and reagents segment dominated the market with its largest revenue share contribution, owing to
the increasing use of consumables for mycoplasma analysis while conducting cell culture research work and related activities.
In terms of technology, the
Polymerase Chain Reaction (PCR) segment held the majority of the market share and is expected to constitute more than half of the market over the forecast period.
High specificity, efficiency, and preciseness are some of the key attributes that make PCR ideal for mycoplasma analysis.
Pharmaceutical & biotechnology companies market segment accounted for over 25% of the
revenue share in 2019 owing to the growing demand for mycoplasma testing for cell culture research and several research & development activities
hydrogen fuel cell vehicle market size, share valuation to surpass USD 28 billion by 2026 - Industry News marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.